Prioritize NGS, liquid biopsy, AI-driven interpretation and strategic partnerships to capitalize on precision oncology, companion diagnostics and early detection.Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) ...

(Nasdaq: CNSY) (“Cerenome” or the “Company ”), today announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to health care professionals in the ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

Purpose: Molecular testing is essential in oncology. Results guide therapy, identify actionable mutations and provide prognostic information. The VA National Oncology Program has compliance goals for ...

Comprehensive upfront biomarker testing, including RAS, BRAF, HER2, and MSI status, now anchors first-line treatment selection in metastatic colorectal cancer, though reflexive testing adoption still ...

The FDA approved a new targeted therapy called Lyrfigtu (lirafugratinib) on September 23, 2026, for a specific type of bile ...

First CNSide payer agreement to include CNSide’s new CSF Molecular Profile tests alongside tumor cell enumerationExpands CNSide contracted payer ...

Camryn was diagnosed with a low-grade glioma at age two after her parents noticed a lazy eye. Sixteen years, 11 brain surgeries and over six years of chemotherapy treatment, Camryn is now ...

The largest ever study of pooled sputum testing shows that combining up to four samples in a single Xpert MTB/RIF Ultra ...

Molecular diagnostics are specialized tests doctors use to look at proteins, RNA, and DNA in and on cancer cells. When you have breast cancer, they show your doctors what’s unique about your tumor so ...